The problem addressed by the present invention is to provide an aqueous ophthalmic composition containing cyclosporine A at a concentration of 0.01-0.08% (w/v), and that is stable, has low eye irritation, and has the property of being clear. The ophthalmic composition containing cyclosporine A can be formulated as a clear aqueous composition by containing a polyethoxylated castor oil derivative and polyethylene glycol, and so concomitantly has favorable stability and safety as an ophthalmic composition. Consequently, the ophthalmic composition containing cyclosporine A can be used favorably in the treatment of dry eye and the like.
